p53 Signaling Pathway Polymorphisms Associated With Emphysematous Changes in Patients With COPD

Area of Science:

• Genetics and Molecular Biology
• Pulmonology
• Cancer Biology

Background:

• The p53 signaling pathway is implicated in the development of emphysema in smokers.
• Genetic variations in p53 (codon 72) affect apoptotic proteins, while MDM2 SNP309 influences MDM2 expression.

Purpose of the Study:

• To investigate the association between p53 and MDM2 gene polymorphisms and pulmonary emphysema in smokers.
• To confirm the role of these single nucleotide polymorphisms (SNPs) in the pathogenesis of smoking-related emphysema.

Main Methods:

• Genotyping of p53 and MDM2 polymorphisms in 365 smokers.
• Assessment of emphysema severity using CT scans.
• Measurement of MDM2 mRNA and p53 protein levels in lung tissues.
• In vitro studies using human lung fibroblasts transfected with p53 and MDM2 SNP plasmids, exposed to cigarette smoke extract (CSE).

Main Results:

• p53 and MDM2 gene polymorphisms correlated with emphysematous lung changes.
• These polymorphisms were also associated with altered p53 protein and MDM2 mRNA levels in lung tissues.
• p53 gene transfection affected fibroblast proliferation, and MDM2 SNP309 promoter activity was modulated by CSE.

Conclusions:

• p53 and MDM2 gene polymorphisms are associated with apoptotic signaling pathways.
• These genetic variations play a role in the pathogenesis of smoking-induced emphysema.